Market News
Smart Trading. Simplified.
Ultra-Low-Priced Mining Stock Rising on Copper's Strength
Copper is outperforming gold as smart investors line up for 2021 gains. Here's an ultra-low-priced copper stock that's developing a high-grade copper deposit in Canada with nearly unlimited upside. Early reports of exceptional mineralization have one major company already jumping in with a $100 million investment. It's not too late for individual investors to get in at the seed level.
Sponsored
Is TTD Stock Overvalued?
The Trade Desk Inc (NASDAQ:TTD) is a global advertising technology company that has you on its radar regardless of whether you have heard of it. It’s the technology partner behind Facebook’s advertising platform, and in September 2019, it positioned itself as a more transparent alternative to Google (GOOG) and Facebook, Inc (NASDAQ:FB). It has the […]
The Top 5 Stocks to Invest in for New Year 2021
2020 will go down in history as the year to forget. All thanks to the coronavirus, U.S. elections, wildfires, earthquakes, riots in the streets, economic disarray, a wild hurricane season, lockdowns... the list goes on. However, markets have perked back up in these final weeks of the year. All on news we may be nearing a desperately needed vaccine. With things looking up as we head into 2021, here are the top 5 hot stocks to buy and hold immediately.
Click Here to Download the FREE Report
Sponsored
Overstock vs Amazon Stock: Which Is Best?
Amazon.com, Inc. (NASDAQ:AMZN) is an ecommerce giant often credited with killing brick-and-mortar retail. From Borders to Sears and J. Crew, the company wreaked havoc on any business slow to shift towards online sales. But Overstock.com Inc (NASDAQ:OSTK) is building buzz as the first real competitor to this online behemoth. This has investors wondering which is […]
3 Tips on How to Trade the New Markets
Want to get in on stocks that are about to skyrocket?
Maximize your gains by getting in a trade before takeoff and riding it out before the downturn.
For this month only, VantagePoint is offering a FREE live class to demonstrate 3 tips to trading the "new markets" in a pandemic-recovering 2021.
Capitalize on potential profits now and reserve your spot today!
Sponsored
Is eHealth Stock A Buy?
Ehealth, Inc (NASDAQ:EHTH) is an online health insurance marketplace focused largely on Medicare. It represents all the major providers, including Aetna, Humana Inc (NYSE:HUM), and UnitedHealth Group Inc (NYSE:UNH). It even owns the Medicare.com domain name, making it a savvy SEO company with a range of websites. You know healthcare and health insurance are important, but […]
Clean Energy Stocks: Rare Metal Discovery & How to Profit in 2021
Investors are preparing for a massive profit windfall come January as the incoming administration sets its $1.7 Trillion Clean Energy Plan in motion. Many clean energy stocks will double in 2021. Yet, this tiny niche is set to deliver gains as high as 2,400%.
Sponsored
What Is The Next GameStop Stock?
GameStop stock’s recent volatility was a wild ride. Shares opened the year under $20, then went sharply, shockingly high over a few days in late January. The peak was about $483 per share, but that didn’t last long. Within a week, prices dropped to about $63 each. Retail investors drove the steep incline through no-fee, […]
Profit-Stocks: Upstart Gold Firm Hits High-Grade Gold Zone
In the gold sector, it's the tiny low-priced exploration firms that typically make the initial discovery through drilling. It's also where investors can secure 10-fold and even 20-fold gains as early drill results are released to the public. Investors are currently jumping into this low-priced gold driller that just secured the crown jewel prize in Australia's richest gold field.
Sponsored
Is Fulgent Genetics Stock A Buy?
Is Fulgent Genetics stock a Buy? Fulgent Genetics Inc (NASDAQ:FLGT) is a clinical genetics testing provider that can perform over 800 tests across 18,000 genes. This includes an at-home COVID-19 test that sparked an avalanche of media buzz, although it can also test for cancers and other rare and genetic diseases. The pandemic will eventually […]
Small Biotech Firm Stuns World
On November 16, 2016 a small biotech used a radical new treatment to restore blindness in mice. CBS News called this breakthrough "the most consequential discovery in biomedicine this century."
Investors who get in early are set to earn 46,751% returns.
Sponsored
View this email online if it doesn't display correctly. This newsletter is not financial advice. Please read our Disclaimer.
To unsubscribe from Financhill, click here.
Financhill is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of Financhill are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.
The sender of this email makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity's compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.
The content on any of Financhill websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The Financhill.com educational training program and software services are provided to improve financial understanding.
The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.
Past performance is no guarantee of future performance. This product is for educational purposes only. Practical application of the products herein are at your own risk and Financhill.com, its partners, representatives and employees assume no responsibility or liability for any use or mis-use of the product. Please contact your financial advisor for specific financial advice tailored to your personal circumstances. Any trades shown are hypothetical example and do not represent actual trades. Actual results may differ. Nothing here in constitutes a recommendation respecting the particular security illustrated.
No comments:
Post a Comment